Co-Diagnostics, Inc. Payments of Stock Issuance Costs
Co-Diagnostics, Inc. (CODX) reported Payments of Stock Issuance Costs of $1.46 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2022-03-24
- Co-Diagnostics, Inc. payments of stock issuance costs for the quarter ending 2020-12-31 was -$1.00.
- Co-Diagnostics, Inc. payments of stock issuance costs for the quarter ending 2020-09-30 was $0.00.
- Co-Diagnostics, Inc. payments of stock issuance costs for the quarter ending 2020-06-30 was $0.00.
- Co-Diagnostics, Inc. payments of stock issuance costs for the quarter ending 2020-03-31 was $1.46M, a 145.95% increase year-over-year.
- Co-Diagnostics, Inc. payments of stock issuance costs for fiscal 2020 was $1.46M, a 145.95% increase from fiscal 2019.
- Co-Diagnostics, Inc. payments of stock issuance costs for fiscal 2019 was $592.76K.
- Co-Diagnostics, Inc. payments of stock issuance costs for fiscal 2017 was $1.09M.
| Period end | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$1.00 derived: sum of 2 quarters · filed 2022-03-24 | -$1.00 derived: sum of 3 quarters · filed 2022-03-24 | $1.46M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $1.46M 10-Q · filed 2021-11-12 | $1.46M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.46M 10-Q · filed 2021-08-12 | $1.46M derived: sum of 3 quarters · filed 2021-11-12 | $1.46M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-03-31 | $1.46M 10-Q · filed 2021-11-12 | $1.46M derived: sum of 2 quarters · filed 2021-11-12 | $1.46M derived: sum of 3 quarters · filed 2021-11-12 | $1.46M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-03-02 | $347.58K 10-K · filed 2021-03-25 | |||||
| 2020-02-13 | $627.44K 10-K · filed 2021-03-25 | |||||
| 2020-01-28 | $482.90K 10-K · filed 2021-03-25 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $592.76K 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $592.76K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $592.76K 10-Q/A · filed 2020-11-03 | ||||
| 2019-03-31 | $592.76K 10-Q · filed 2020-05-14 | |||||
| 2019-02-28 | $592.76K 10-K · filed 2021-03-25 | |||||
| 2017-12-31 | $1.09M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |